Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

US Patent 6933311 · Granted Aug 23, 2005

Estimated economic value: $125,490,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Certain pladienolide compounds and methods of use2024
Diagnosis and treatment of psoriatic arthritis2023
Diagnosis and treatment of psoriatic arthritis2022
S1P modulating agents2021
Tetrasubstituted alkene compounds and their use2020
Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R2020
Glass treatment apparatus and methods of treating glass2020
Fused heterocyclic compounds as S1P modulators2020
SIP modulating agents2019
Substituted pyrrolidines and methods of use2019
Tricyclic modulators of TNF signaling2019
Tricyclic modulators of TNF signaling2019